期刊文献+

骨密度的临床意义、检测方法及影响因素 被引量:6

The clinical significance,detection methods and influencing factors of bone mineral density
下载PDF
导出
摘要 骨密度是反映骨骼状况的客观参数,目前广泛应用于检测骨质疏松症、预测骨折风险、改善慢性阻塞性肺疾病的预后等方面,临床上常规采用双能X线吸收测定法和定量超声法进行检测,近年逐步发展为定量CT、磁共振成像等其他方法,测量结果易受体质量、年龄、性别、激素等因素影响。建议应针对不同测量方法的特点,根据不同情况做出最优选择,并在分析测量结果时广泛考虑可能影响数据的因素,以对骨骼情况做出最精确的判断。 Bone mineral density(BMD)is an objective reference for the health condition of bone.It’s widely used to diagnose osteoporosis,predict fracture risk and improve prognosis of chronic obstructive pulmonary diseases at present.Generally,dual energy X-ray absorptiometry and quantitative ultrasound are used for BMD examination in clinical practice.Other methods,such as quantitative CT and magnetic resonance imaging have been gradually developed in recent years.The measurement of BMD could be influenced by target weight,age,sex,hormone level,etc.It’s suggested that the optimal selection should be made based on the characteristics of different measurement methods,and the negative influence of other factors should be realized and excluded as far as possible to make more accurate judgment on the bone condition.
作者 彭宜 琼仙 王威 张世林 魏梦轩 金波 PENG Yi;QIONG Xian;WANGWei;ZHANG Shilin;WEI Mengxuan;JIN Bo(Department of Medical Imaging,North Sichuan Medical College,Nanchong,Sichuan,637000,China;Department of Radiology,the Second Affiliated Hospital of North Sichuan Medical College,Nanchong,Sichuan,637100,China;Department of Forensic Medicine,North Sichuan Medical College,Nanchong,Sichuan,637000,China)
出处 《当代医学》 2021年第27期191-194,共4页 Contemporary Medicine
基金 四川省科技厅应用基础研究面上项目(2018JY0497) 2019年法医病理学公安部重点实验室开放课题(GAFYBL201904) 川北医学院博士科研启动基金(CBY16-QD05) 四川/国家大学生创新训练计划项目(S/202010634028)。
关键词 骨密度 临床意义 检测方法 影响因素 Bone mineral density Clinical significance Measurement Influencing factors
  • 相关文献

参考文献4

二级参考文献42

  • 1董进,南冀萍,张志利,刘望彭,刘晋敏,王萍.西部地区正常人群定量超声骨量分布的研究[J].中国骨质疏松杂志,1997,3(1):60-63. 被引量:17
  • 2唐海,罗先正,任素梅.跟骨超声骨质测量与双能量X线吸收骨密度测量的比较[J].中国骨质疏松杂志,1996,2(2):33-35. 被引量:10
  • 3余卫.骨质疏松诊断及骨矿含量测定方法[J].中国临床医生杂志,2006,34(7):7-11. 被引量:10
  • 4Gormalli S, CaffareUi C, Nuti R. Obesity and fracture risk[J]. Clinical Cases in Mineral.and Bone Metabolism, 2014, 11(1): 9-14.
  • 5Bermeo S, Gunaratnarn K, Duque G. Fat and Bone Interactions[J]. Current Osteoporosis Reports, 2014, 12(2): 235-242.
  • 6Campos RM, de Piano A, da Silva PL, et al. The role of pro/anti-inflam matory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy[J]. Endocrine, 2012, 42(1): 146-156.
  • 7Sharma S, Tandon VR, Mahajan S, et al. Obesity: Friend or foe for osteoporosis[J]. Journal of Mid-life Health, 2014, 5(1): 6-9:.
  • 8Gunaratnam K, Vidal C, Gimble JM, et al. Mechanisms of palmitateinduced lipotoxicity in human osteoblasts[J]. Endocrinology, 2014, 155(1): 108-116.
  • 9Beck GR Jr, Khazai NB, Bouloux GF. The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes[J]. Transl Res, 2013, 161(3): 145-155.
  • 10Cohen A, Dcmpster DW, Rocker RR, et al. Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premcnopausal women: a transiliac bone biopsy study[J]. J Clin Endocrinol Mctab, 2013, 98(6): 2562-2572.

共引文献44

同被引文献63

引证文献6

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部